Protai

Proteomics Centered AI Powered Drug Discovery Platform

Startup

Protai is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2021. Proteomics Centered AI Powered Drug Discovery Platform. The company has raised a total of $20M across 2 funding rounds, currently at the Seed stage. Protai was founded by Eran Seger and Kirill Pevzner. Key investors include Pitango HealthTech, Grove Ventures. The company has 11-50 employees. Core technologies: Artificial Intelligence, Machine Learning, Platforms & Interfaces, Software.

With $20M in total funding, Protai is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.

$20M
Raised
2
Rounds
2
Investors
2
Team
2021
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentArtificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
At a Glance
Investors
Founders
In the News

5 articles covered by sources including www.prnewswire.com, www.calcalistech.com, venturebeat.com.

www.prnewswire.com · Oct 23, 2025
/PRNewswire/ -- Protai, www.protai.bio, a structural proteomics and AI-driven biotech, announced its participation in four major scientific conferences this...
Read article ↗
Frequently Asked Questions
What does Protai do?

Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. The company is building machine learning models combining deep proteomics to identify up to 1 million proteoforms, including post-translational modifications, protein-protein interactions, quantifications, and different structural populations of proteins.

How much funding has Protai raised?

Protai has raised $20M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Pitango HealthTech, Grove Ventures.

Who founded Protai?

Protai was founded in 2021 by Eran Seger (Co-founder & CEO), Kirill Pevzner (Co-founder & CTO).

What sector is Protai in?

Protai operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Machine Learning, Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is Protai located?

Protai is based in Tel Aviv, Israel, Center District.

View Full Profile Classic View Website ↗